Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale Read more
T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy Read more
Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union Read more
Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer Read more
Novartis Piqray data show survival benefit for patients with HR+/HER2- advanced breast cancer with a PIK3CA mutation Read more